Prohost BiotechResearch Platform

Home Articles Categories Tags Subscribe

Loading articles...

Prohost BiotechResearch Platform

Advancing biotechnology through cutting-edge research, innovation, and scientific collaboration.

Platform

Articles Categories Tags

Resources

About Us FAQ Contact Privacy Policy Terms & Conditions Cookie Policy

© 2026 Prohost Biotech. All rights reserved. Prohost Biotech is a registered trademark of Prohost Biotech.

Prohost BiotechResearch Platform

Home Articles Categories Tags Subscribe

Tag

#argenx SE (ARGX)

1 article found with this tag

Showing 1 to 1 of 1 articles

FDA Approval of argenx Product VYVGART Hytrulo for Patients with CIDP

argenx in the NEWS argenx SE ( ARGX ) announced that the U.S. FDA has approved VYVGART Hytrulo (efgartigimod alfa and hyaluronidase-qvfc) for adult patients with chronic inflammatory demyelinating pol...

Prohost Biotech

Jun 24, 2024

Prohost BiotechResearch Platform

Advancing biotechnology through cutting-edge research, innovation, and scientific collaboration.

Platform

Articles Categories Tags

Resources

About Us FAQ Contact Privacy Policy Terms & Conditions Cookie Policy

© 2026 Prohost Biotech. All rights reserved. Prohost Biotech is a registered trademark of Prohost Biotech.